Glucotrack (GCTK),announced that Guillermo Umpierrez, MD, CDCES, FACE, MACP, has been named as Glucotrack’s new Medical Advisory Board member, effective immediately.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GCTK:
- GlucoTrack’s $3.03M Stock Offering Agreement Announced
- GlucoTrack prices offering of 2.6M shares of common stock at $1.15
- GlucoTrack Announces Reverse Stock Split and Clinical Study Success
- GlucoTrack announces completion of first in human clinical study of CGM
- GlucoTrack Inc trading halted, news pending